November 06, 2017
Article
The virulent pathogen has significant individual and public health implications.
Regdanvimab—A New Attack of the (Mono)Clones
FDA Lifts Clinical Hold of Lenacapavir for HIV Treatment and Prevention
First In-Africa Clinical Trial of mRNA HIV Vaccine
Fourth COVID-19 Vaccine Dose Boosts Immunity Above Third Shot